Non-vitamin K oral anticoagulants in adults with congenital heart disease

quod non?

  • Verhamme, Peter
  • Budts, Werner
  • Van de Werf, Frans

  • Division of Cardiovascular Diseases, University Hospitals Leuven and Department of Cardiovascular Sciences, KU Leuven–University of Leuven, Belgium

Corresponding author, Department of Cardiovascular Sciences, KU Leuven–University of Leuven, Herestraat 49, B-3000 Leuven, Belgium. Tel: + 32 16 34 42 35, Email: [email protected]

This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model)

European Heart Journal 41(43):p 4178-4180, November 14, 2020. | DOI: 10.1093/eurheartj/ehaa867

Corresponding Article

Current use and safety of novel oral anticoagulants in adults with congenital heart disease

results of a nationwide analysis including more than 44 000 patients

  • Freisinger, Eva
  • Gerß, Joachim
  • Makowski, Lena
  • Marschall, Ursula
  • Reinecke, Holger
  • Baumgartner, Helmut
  • Koeppe, Jeanette
  • Diller, Gerhard-Paul
European Heart Journal 41(43):p 4168-4177, November 14, 2020. | DOI: 10.1093/eurheartj/ehaa844
Copyright © Copyright Oxford University Press 2020.